Pathways modulating memory-like properties in NK cells and their impact on HIV control
调节 NK 细胞记忆样特性的途径及其对 HIV 控制的影响
基本信息
- 批准号:10673150
- 负责人:
- 金额:$ 24.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Activated Natural Killer CellAddressAfrican Green MonkeyAftercareAgonistAnimal ModelAntibodiesAntigensAreaAttenuatedAutologousB-Cell ActivationB-LymphocytesBCG LiveBacillusBovine TuberculosisCellsCharacteristicsDNA MethylationDataDevelopmentDrug ModulationEnhancersEpigenetic ProcessFCGR3B geneFDA approvedFutureGenerationsGoalsHIVHIV InfectionsHIV vaccineHistone AcetylationHumanIFNG geneIL18 geneIn VitroIndividualInfectionInnate Immune SystemInterferon Type IIInterleukin-12Interleukin-15Interleukin-2InterventionLightMacacaMalignant NeoplasmsMediatingMemoryModificationMycobacterium bovisNatural Killer CellsNuclearPathway interactionsPeptidesPlayPrimary InfectionProliferatingPropertyResearchResearch ProposalsRoleSIVSignal PathwaySignal TransductionTNF geneTestingToll-like receptorsToxic effectTranscriptional ActivationTransducersVaccinationViralViremiaVirusVirus Replicationantibody-dependent cell cytotoxicitycomparative efficacycytokinecytotoxicityhistone methylationhumanized mousein vivoin vivo Modelmouse modelpre-clinicalresponsesimian human immunodeficiency virustherapeutic developmenttranscription factorvaccination against tuberculosisvaccine developmentvaccine trial
项目摘要
Project Summary
Natural Killer (NK) cells are part of the innate immune system and play an important role in controlling HIV
infection. NK cells have been shown to control of SIV replication in the B cell follicles of African Green
Monkeys and in the decrease in acquisition of SHIV in macaques in a vaccination study. Furthermore, studies
presented at CROI2015 and AIDS2018 highlight the importance of NK cells controlling HIV infection in
humans. These studies showed stronger NK responses in post-treatment controllers from the VISCONTI
study. All these previous studies highlight the importance of harnessing NK cells to develop a protective HIV
vaccine or a cure. Recently NK cells have been shown to have ‘adaptive’ or ‘memory-like’ properties. These
properties include a quantitatively and qualitatively increased effector response upon restimulation; enhanced
proliferation in response to low levels of IL-2 or IL-15; enhanced survival in vivo; and enhanced cytolytic
response against different malignancies. In the context of HIV, pre-existing memory-like NK cells have been
shown to control viremia during primary infection. To that end, understanding the signaling pathways and
mechanisms promoting the generation of memory-like NK cells could lead to the development of therapeutic
strategies to enhance HIV control mediated by memory-like NK cells both in the context of vaccine
development and cure interventions. Our preliminary data supports the hypothesis that memory-like NK cells
have an enhanced ability to control HIV infection relative to conventional NK cells. In Aim 1, we will define the
signaling pathways that promote the generation of memory-like NK cells. Specifically, we will investigate the
role of cytokines, antibodies and Toll-like receptor agonists inducing memory-like NK cells. One of the
hallmarks of memory-like NK cells is the epigenetic remodeling of the IFN-γ locus characterized by reduced
DNA methylation and enhanced IFN-γ upon restimulation. As such, we will investigate how DNA methylation
as well as other epigenetic marks such as histone acetylation and histone methylation regulate the generation
of memory-like NK cells. In Aim 2, we will further investigate the ability of memory-like NK cells to control HIV
infection using both in vitro and in vivo models. We will expand our studies to include different viral strains and
evaluate both natural cytotoxicity and antibody-dependent cellular toxicity. The ultimate goal of these research
proposal will be to elucidate signaling pathways that lead to the enhancement of the generation of memory-like
NK cells. If successful, we will provide preclinical data to develop interventions to enhance memory-like NK
effector functions in the context of HIV vaccination and/or cure strategies.
项目概要
自然杀伤 (NK) 细胞是先天免疫系统的一部分,在控制 HIV 方面发挥着重要作用
感染。 NK 细胞已被证明可以控制非洲绿 B 细胞滤泡中的 SIV 复制
猴子以及在疫苗接种研究中猕猴感染 SHIV 的减少。此外,研究
在 CROI2015 和 AIDS2018 上发表的论文强调了 NK 细胞控制 HIV 感染的重要性
人类。这些研究表明 VISCONTI 的治疗后控制器有更强的 NK 反应
学习。所有这些先前的研究都强调了利用 NK 细胞开发保护性 HIV 的重要性
疫苗或治疗方法。最近,NK 细胞被证明具有“适应性”或“类记忆”特性。这些
特性包括在再刺激时在数量和质量上增加的效应器反应;增强型
低水平 IL-2 或 IL-15 导致的增殖;提高体内存活率;和增强的细胞溶解作用
针对不同恶性肿瘤的反应。在艾滋病毒的背景下,预先存在的记忆样 NK 细胞已被
显示可控制原发感染期间的病毒血症。为此,了解信号通路并
促进记忆样 NK 细胞生成的机制可能会导致治疗药物的开发
在疫苗背景下增强记忆样 NK 细胞介导的 HIV 控制的策略
发展和治疗干预措施。我们的初步数据支持这样的假设:记忆样 NK 细胞
相对于传统的 NK 细胞,其控制 HIV 感染的能力更强。在目标 1 中,我们将定义
促进记忆样 NK 细胞生成的信号通路。具体来说,我们将调查
细胞因子、抗体和 Toll 样受体激动剂在诱导记忆样 NK 细胞中的作用。中的一个
记忆样 NK 细胞的标志是 IFN-γ 位点的表观遗传重塑,其特征是减少
再刺激后 DNA 甲基化和 IFN-γ 增强。因此,我们将研究 DNA 甲基化如何
以及其他表观遗传标记,例如组蛋白乙酰化和组蛋白甲基化,调节生成
记忆样 NK 细胞。在目标2中,我们将进一步研究记忆样NK细胞控制HIV的能力
使用体外和体内模型进行感染。我们将扩大我们的研究范围,以包括不同的病毒株和
评估天然细胞毒性和抗体依赖性细胞毒性。这些研究的最终目的
提案将阐明导致增强类记忆生成的信号通路
NK 细胞。如果成功,我们将提供临床前数据来开发增强记忆样 NK 的干预措施
HIV 疫苗接种和/或治疗策略中的效应器功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alberto Bosque其他文献
Alberto Bosque的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alberto Bosque', 18)}}的其他基金
Defining HIV Env protein expression in latently infected cells
定义潜伏感染细胞中的 HIV 包膜蛋白表达
- 批准号:
10762524 - 财政年份:2023
- 资助金额:
$ 24.23万 - 项目类别:
Ultrasensitive Env Detection Assay for Broadly Neutralizing Antibody Screening
用于广泛中和抗体筛选的超灵敏包膜检测分析
- 批准号:
10676393 - 财政年份:2023
- 资助金额:
$ 24.23万 - 项目类别:
Pathways modulating memory-like properties in NK cells and their impact on HIV control
调节 NK 细胞记忆样特性的途径及其对 HIV 控制的影响
- 批准号:
10534402 - 财政年份:2022
- 资助金额:
$ 24.23万 - 项目类别:
Training in HIV Persistence, Co-morbidities and Therapeutics
HIV 持续性、合并症和治疗方面的培训
- 批准号:
10326881 - 财政年份:2021
- 资助金额:
$ 24.23万 - 项目类别:
Training in HIV Persistence, Co-morbidities and Therapeutics
HIV 持续性、合并症和治疗方面的培训
- 批准号:
10657673 - 财政年份:2021
- 资助金额:
$ 24.23万 - 项目类别:
Developing Pathogen Recognition Receptor Agonists as Latency Reversing Agents
开发病原体识别受体激动剂作为潜伏期逆转剂
- 批准号:
9501675 - 财政年份:2016
- 资助金额:
$ 24.23万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.23万 - 项目类别:
Research Grant














{{item.name}}会员




